Literature DB >> 22552815

[Impaired cognitive function and structural changes in cerebral white matter after chemotherapy].

M Wilhelm1.   

Abstract

Entities:  

Year:  2012        PMID： 22552815     DOI： 10.1007/s00066-012-0111-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

1.  Cognitive dysfunction in people with cancer.

Authors:  Sanne B Schagen; Janette Vardy
Journal:  Lancet Oncol       Date:  2007-10       Impact factor: 41.316

Review 2.  Reciprocal regulation of the neural and innate immune systems.

Authors:  Michael R Irwin; Steven W Cole
Journal:  Nat Rev Immunol       Date:  2011-08-05       Impact factor: 53.106

3.  Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  Breast Cancer Res Treat       Date:  2010-08-06       Impact factor: 4.872

4.  Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant.

Authors:  Karen L Syrjala; Sureyya Dikmen; Shelby L Langer; Sari Roth-Roemer; Janet R Abrams
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113
  4 in total
  1 in total

1.  CyberKnife robotic image-guided stereotactic radiotherapy for oligometastic cancer : A prospective evaluation of 95 patients/118 lesions.

Authors:  B A Jereczek-Fossa; I Bossi-Zanetti; R Mauro; G Beltramo; L Fariselli; L C Bianchi; C Fodor; P Fossati; G Baroni; R Orecchia
Journal:  Strahlenther Onkol       Date:  2013-04-21       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.